Target intelligence / Profile preview

Novel transcript, antisense to ALDH1A3

Molecular classification: Other (non-coding RNA, potentially long non-coding RNA)

Overview

Novel transcript, antisense to ALDH1A3 (ENSG00000278456), is a non-coding RNA transcript locus identified in genomic surveys and located antisense to the ALDH1A3 gene. There is currently no experimental evidence supporting a protein product or direct biological function, nor is it classified as a therapeutic or diagnostic target. Its significance, if any, is presently unclear. Most references describe it solely based on genomic location[1].

Beyond the preview

Go deeper on Novel transcript, antisense to ALDH1A3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to ALDH1A3.

Explore the full profile